The expert recommendations addressed clinical workflow, guideline creation, and reimbursement barriers to precision oncology.

The researchers previously received a single-patient approval to administer a second dose of the treatment in the study.

The drugmaker met increased demand following approval of Carvykti in earlier lines of therapy with expanded production at US and European facilities.

The partners will incorporate BostonGene's Tumor Portrait tests into SCRI's Phase I clinical trials to explore the use of HLA typing for pre-screening patients.

Investigators will evaluate the safety, tolerability, and exploratory signs of efficacy, including neurofilament light chain and SOD1 protein.

Treatment with the vaccine did not improve progression-free survival in patients with HPV16-positive cervical and anogenital tumors.

Certain members of MotivHealth's HSA-based insurance plans will have access to DecisionRx's medication therapy optimization program.

Drugmakers and insurers are exploring different payment schemes for expensive, potentially curative treatments, particularly ones tied to patient response.

Seven of 67 patients who received the cerebral adrenoleukodystrophy gene therapy developed blood cancer, though most cases ...

The firm is gearing up for a registration-directed trial based on a positive Phase Ib readout and after discussions with US ...

With A$45 million in funding, the group will focus on research developing safer therapies and clinical trial programs for pediatric cancer treatment.

The drugmaker wants to establish Enhertu in HER2-ultralow breast cancer and even HER2-negative tumors but remains committed to precision medicine strategies.